The first iteration of HER2-targeted drugs showed limited activity in bladder cancer, but the rise of antibody-drug ...

While Natera said it will seek FDA approval for Signatera based on data from IMvigor011, the readout from another ctDNA-guided de-escalation study was more nuanced.

Marc Hickel thought his battle with prostate cancer was over after surgery and radiation treatment. But five years later, ...

Enfortumab vedotin plus pembrolizumab improved EFS, OS, and pCR rates in MIBC patients ineligible for cisplatin-based chemotherapy. The combination therapy showed a median EFS and OS that were not ...

TWELVE members of the East Cornwall Harriers are preparing to take on the challenging Cornish Marathon on November 2, running in support of fellow club member Craig Vaughnley, who is currently ...

Tecentriq may be used with the medicines paclitaxel protein-bound and carboplatin as your first treatment when your lung cancer: has spread or grown, and is a type called “non-squamous NSCLC”, and ...

IT’S been 18 months since Evan Francis last peed naturally, and shockingly she never will again. Her ordeal started with an ...

Durvalumab addition to BCG therapy significantly improved DFS in BCG-naive, high-risk NMIBC patients, achieving a 32% reduction in DFS event risk. The combination therapy was well-tolerated, with ...

Inlexzo is supplied as a single-dose intravesical system containing 225mg of gemcitabine plus a sterile urinary catheter and stylet.

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

Frailty-associated gut dysbiosis significantly increases the risk for gastrointestinal complications following robot-assisted ...

To kick things off, we'll set the stage on what defines non-muscle invasive bladder cancer and how we triage patient ...